Biotransformation of 2-phenyl-4-/beta-dimethylamino-ethyl/-6-methyl-2,3-dihydro-1,4-benzoxazine-3-one ("AR 17 O48) a potential antirheumatic agent
Pfeifer, S.; Bornschein, I.; Gehrke, A.
Die Pharmazie 32(10): 587-592
1977
ISSN/ISBN: 0031-7144 PMID: 607217 Document Number: 122494
Document emailed within 1 workday
Related Documents
Sugawara, T.; Yoshida, M.; Shimoda, K.; Takada, S.; Miyamoto, M.; Nomura, M.; Kato, M. 1996: One-month oral toxicity study of the new quinolone antibacterial agent (S)-10-[(S)-(8-amino-6-azaspiro[3,4]octan-6-yl)-9-fluoro-2,3-dihydro-3- methyl-7-oxo-7H-pyrido [1,2,3-de] [1,4] benzoxazine-6-carboxylic acid hemihydrate in rats and cynomolgus monkeys Arzneimittel-Forschung 46(7): 705-710Boissier, J.R.; Simon, P.; Zaczinska, M.; Fichelle, J. 1972: Experimental psychopharmacologic study of a new psychotropic drug, 2-ethylamino-6-chloro-4-methyl-4-phenyl-4H-3,1-benzoxazine Therapie 27(2): 325-338
Coudert, P.; Rubat, C.; Couquelet, J.; Tronche, P. 1990: Synthesis of 6-[(4-imidazol-1-yl)-phenyl]-4-phenyl 4,5-dihydro-2H-pyridazin-3-one: a potential blood platelet aggregation inhibitor Journal de Pharmacie de Belgique 45(3): 191-195
Mayr, C.A.; Sami, S.M.; Remers, W.A.; Dorr, R.T. 1998: Identification and characterization of in vitro metabolites of 2-[2'-(dimethylamino)ethyl]-1,2-dihydro-3H-dibenz [de,h]isoquinoline-1,3-dione (Azonafide) Drug Metabolism and Disposition: the Biological Fate of Chemicals 26(2): 105-109
Lan, S.J.; Chando, T.J.; Cohen, A.I.; Weliky, I.; Schreiber, E.C. 1973: Metabolism of 4-(3-(dimethylamino)propyl)-3,4-dihydro-2-(1-hydroxyethyl)-3-phenyl-2H-1,4-benzothiazine (SQ 11,579) under in vitro and in vivo conditions by rats, dogs, and monkey Drug Metabolism and Disposition: the Biological Fate of Chemicals 1(4): 619-627
Herzig, J.W.; Chiesi, M.; Depersin, H.; Grüninger, S.; Hasenfuss, G.; Kubalek, R.; Leutert, T.; Pieske, B.; Pioch, K.; Wenk, P.; Holubarsch, C. 1996: Ca2+ sensitization in idiopathic dilated human myocardium. Differential in vitro effects of (+)-(5-methyl-6-phenyl)-1,3,5,6-tetrahydro-3,6-methano-1,5-benzodiazoci ne-2,4-dione, a novel purely Ca2+sensitizing agent, and (+)-5-(1-(3,4-dimethoxybenzoyl)-1,2,3,4-tetrahydroquinolin-6-yl)-6-meth yl-3, 6-dihydro-2H-1,3,4-thiadiazin-2-one on skinned fibres and isolated ventricular strips Arzneimittel-Forschung 46(6): 586-593
Vollmer, K.O.; Koss, F.W. 1970: Synthesis of DL-trans-2-dimethylamino-i-phenyl-cyclohex-3-en-trans-1-carboxylic acid ethyl ester-(6-14C)-hydrochloride Arzneimittel-Forschung 20(8): 990-992
Mosti, L.; Menozzi, G.; Schenone, P.; Dorigo, P.; Gaion, R.M.; Belluco, P. 1992: Synthesis and cardiotonic activity of 2-substituted 5-cyano-1,6-dihydro-6-oxo-3-pyridinecarboxylic acids and their methyl or ethyl esters Farmaco 47(4): 427-437
Bruno, O.; Ranise, A.; Bondavalli, F.; Schenone, P.; D'Amico, M.; Filippelli, A.; Filippelli, W.; Rossi, F. 1993: 3,5-diphenyl-1H-pyrazole derivatives. XI. N-aryl-5(3)-phenyl-4-(3,5- diphenyl-1-pyrazolyl)-3(5)-pyrazole amines, 5-substituted 4,5-dihydro-3-phenyl-4-(3,5-diphenyl-1-pyrazolyl)-1H-pyrazoles and 2,6-disubstituted 1,6-dihydro-4- phenyl-5-(3,5-diphenyl-1-pyrazolyl)pyrimidines with antipyretic, antiinflammatory and other activities Farmaco 48(7): 949-966
Zhou, Y.J.; Zhang, W.N.; Lu, J.G.; Li, K.; Zhu, J. 1997: Synthesis and antifungal activities of 1-(2-[(substituted-phenyl) methyl]thio)-2-(2,4-difluorophenyl)ethyl-1H-1,2,4-triazoles Yao Xue Xue Bao 32(12): 902-907
Puglishi, C.V.; de Silva, J.A. 1976: Determination of 7-iodo-1,3-dihydro-1-methyl-5(2'-fluorophenyl)-2h-1,4-benzodiazepin-2-one (Ro 7-9957) and its major biotransformation products in blood and urine by electron capture-gas-liquid chromatography Journal of Chromatography 118(3): 370-386
Hagen, V.; Rumler, A.; Klauschenz, E.; Hagen, A.; Heer, S.; Faust, G.; Mitzner, R. 1990: Potential cardiotonics. 7. Synthesis and cardiovascular effects of 5-(4-pyridinyl)-, 6-methyl-4-(4-pyridinyl) and 6-methyl-5-phenyl-substituted 3-cyano-2-aminoalkylamino-pyridines Die Pharmazie 45(4): 240-241
Gülerman, N.; Rollas, S.; Ulgen, M. 1998: Synthesis and in vitro microsomal metabolism of 4-ethyl-5-(4-fluorophenyl)-2,4-dihydro-3H-1,2,4-triazole-3-thione and its potential metabolites Bollettino Chimico Farmaceutico 137(5): 140-143
Saxena, R.; Iyer, R.N.; Anand, N.; Chatterjee, R.K.; Sen, A.B. 1970: 3-Ethyl-8-methyl-1,3,8-triazabicyclo(4,4,0)decan-2-one: a new antifilarial agent Journal of Pharmacy and Pharmacology 22(4): 306-307
Lindner, E. 1984: L-3,4-(3-3,4-dimethoxyphenethylamino-2-hydroxypropoxy)-phenyl- crotonic acid nitrile.HCl (Hoe 224), a beta-blocking agent with high beta 1-selectivity Arzneimittel-Forschung 34(3): 270-276
Waisser, K.; Gregor, J.; Holý, P.; Kubicová, L.; Klimesová, V.; Kaustová, J. 2001: Antimicrobial salicylanilides and 3-phenyl-2H-1,3-benzoxazine-2,4(3H)-diones Ceska a Slovenska Farmacie: Casopis Ceske Farmaceuticke Spolecnosti a Slovenske Farmaceuticke Spolecnosti 50(3): 148-152
Harik, S.I.; Schmidley, J.W.; Iacofano, L.A.; Blue, P.; Arora, P.K.; Sayre, L.M. 1987: On the mechanisms underlying 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity: the effect of perinigral infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, its metabolite and their analogs in the rat Journal of Pharmacology and Experimental Therapeutics 241(2): 669-676
Ishimori, T.; Gotanda, K.; Sasaki, T.; Shinbo, A.; Asano, H.; Miyazawa, K.; Miyasaka, K. 1994: Cardiac effects of the novel pyridazinone derivative 6-[4-[2-[3-(5-chloro-2-cyanophenoxy)-2-hydroxypropylamino]- 2- methylpropylamino]phenyl]-4,5-dihydro-5-methyl-3(2H) pyridazinone monoethyl maleate and its metabolite in isolated heart preparations of guinea pigs and dogs Arzneimittel-Forschung 44(5): 583-588
Yan, L.; Xu, B.; Ma, Z.; Zhu, Y.; Yang, Q. 1998: Synthesis and antibacterial activity of 7-substituted-1-ethyl(2-fluoro-ethyl)-6,8-difluoro-1,4-dihydro-4- oxoquinoline-3-carboxylic acid Yao Xue Xue Bao 33(5): 392-395
Nakamura, H.; Yokoyama, Y.; Motoyoshi, S.; Ishii, K.; Imazu, C.; Seto, Y.; Kadokawa, T.; Shimizu, M. 1983: The pharmacological profile of 2-(8-methyl-10,11-dihydro-11-oxodibenz[b,f]oxepin-2-yl)propionic acid (AD-1590), a new non-steroidal anti-inflammatory agent with potent antipyretic activity Arzneimittel-Forschung 33(11): 1555-1569